Dr. Jon C. Stringer, M.D.
Internal Medicine (Internal Medicine Physician)
- Medicare participating
At a glance
- Years since graduation
- 55
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 111
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
NY license 141135
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University Hospital S U N Y Health Science Center Syracuse, NY
- Crouse Hospital Syracuse, NY
- Oswego Hospital Oswego, NY
- Cayuga Medical Center at Ithaca Ithaca, NY
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 111
- Services billed
- 1,306
- Patients’ average age
- 84
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 236 | 89 |
| Insertion of needle into vein for collection of blood sample | 208 | 95 |
| Established patient office or other outpatient visit, 20-29 minutes | 104 | 60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 96 | 82 |
| Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | 83 | 31 |
| Established patient office or other outpatient visit, 40-54 minutes | 74 | 66 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 72 | 72 |
| Stool analysis for blood to screen for colon tumors | 61 | 61 |
| Influenza vaccine split virus, preservative free | 56 | 56 |
| Administration of influenza virus vaccine | 56 | 56 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 13 payments worth $244 in total to this clinician.
| Lilly USA, LLC | $77.43 |
|---|---|
| GlaxoSmithKline, LLC. | $38.71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.46 |
| Exact Sciences Corporation | $20.39 |
| Alnylam Pharmaceuticals Inc. | $19.70 |
| Amgen Inc. | $18.53 |
| Esperion Therapeutics, Inc. | $17.12 |
| Pfizer Inc. | $15.77 |
| Food and Beverage | $244 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $325 in research payments for these studies, mostly to the institutions running them.
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
Eli Lilly and Company · Completed · NCT05971940
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.